Patent Number: 6,166,070

Title: Kodaistatins A, B, C and D, a process for their production and their use

Abstract: Kodaistatins A and B, compounds of the molecular formula C.sub.35 H.sub.34 O.sub.11, and Kodaistatins C and D, compounds of the molecular formula C.sub.35 H.sub.34 O.sub.12, have antidiabetic activity.

Inventors: Ramakrishna; Nirogi Venkata Satya (Mumbai, IN), Swamy; Keshavapura Hosamane Sreedhara (Mumbai, IN), Vijayakumar; Erra Koreswara Satya (Mumbai, IN), Nadkarni; Suresh Rudra (Bombay, IN), Jayvanti; Kenia (Mumbai, IN), Herling; Andreas (Bad Camberg, DE), Kogler; Herbert (Glashutten, DE), Vertesy; Laszlo (Eppstein, DE), Panshikar; Rajan Mukund (Maharashtra, IN), Sridevi; Kota (Mumbai, IN), Raman; Mythili (Mumbai, IN), Dalal; Roda Maneck (Mumbai, IN)

Assignee: Aventis Pharma Deutschland GmbH

International Classification: A61K 31/00 (20060101); C07D 307/00 (20060101); C07D 307/60 (20060101); C12P 7/00 (20060101); C12N 1/02 (20060101); A61K 031/34 (); C07D 307/32 ()

Expiration Date: 12/26/2017